GPBAR1 and obesity disorder: Watanabe et al. showed that TGR5 stimulates energy expenditure through the induction of a cAMP-dependent thyroid hormone-activating enzyme, type II iodothyronine deiodinase (Dio2), in BAT and prevents high-fat-diet-induced obesity and insulin resistance [5].